Found 200 matching trials
A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma PHASE2 The study is being conducted to evaluate the efficacy and safety of convers...
Show More Location
Shandong Cancer Hospital and Institute
Learn More & Join Trial
Camrelizumab in Patients With Unresectable Hepatocellular Carcinoma N/A Primary liver cancer is the second most common cause of cancer death in Chi...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping. N/A Extensive research employing diverse omics methodologies has unveiled a var...
Show More Location
Fujian Medical University Union Hospital
Learn More & Join Trial
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma N/A This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Show More Location
The Second Affiliated Hospital of Fujian Medical University
Learn More & Join Trial
Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Cancer PHASE2 The study is being conducted to evaluate the efficacy, safety and tolerabil...
Show More Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Learn More & Join Trial
Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study PHASE2 This is a single arm, open-label, non-randomized and single-center phase II...
Show More Learn More & Join Trial
Hepatectomy Combined With Camrelizumab and Apatinib in CNLC Stage IIIb HCC PHASE2 This study intends to prospectively enroll CNLC stage IIIb HCC cases with e...
Show More Location
Guangxi Medical University Cancer Hospital
Learn More & Join Trial
Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer PHASE1 The purpose of this study is to observe and preliminary explore the efficac...
Show More Location
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Learn More & Join Trial
An Exploratory Trail of Camrelizumab Plus Apatinib Mesylate for Advanced Gastrointestinal PHASE2 At present, surgery, radiotherapy and chemotherapy are the main treatment m...
Show More Location
Harbin Medical University
Learn More & Join Trial
A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab Versus Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification PHASE3 This study was designed to evaluate the effectiveness and safety of hepatic...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial